MODERN DIAGNOSTIC AND RESEARCH CENTRE LIMITED IPO
MODERN DIAGNOSTIC AND RESEARCH CENTRE LIMITED was a SME IPO, offered at ₹85–₹90 per share. The issue was subscribed 350.49× overall (QIBs 193.51×, NIIs 519.38×, retail 342.46×).
Frequently asked questions
- How many times was the MODERN DIAGNOSTIC AND RESEARCH CENTRE LIMITED IPO subscribed?
- The MODERN DIAGNOSTIC AND RESEARCH CENTRE LIMITED IPO was subscribed 350.49× overall — 193.51× in the QIB category, 519.38× among non-institutional investors, 342.46× in retail.
- What were the retail allotment odds for the MODERN DIAGNOSTIC AND RESEARCH CENTRE LIMITED IPO?
- Retail was subscribed 342.46×, so a single-lot application had roughly a 0.3% chance of allotment (about 1 in 342), and allotment was finalised on 5 Jan 2026.
- What was the price band and lot size of the MODERN DIAGNOSTIC AND RESEARCH CENTRE LIMITED IPO?
- The price band was ₹85–₹90 per share.